Abstract
Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors that have been implicated in tumoral transformation, especially in hematological malignancies. Because of this, the JAK/STAT pathway is attractive as a therapeutic target in these tumors. In the present study, we analyzed the ability of fludarabine and two JAK kinase inhibitors, AG490 and WHI-P131, to block STAT1 activation and induce apoptosis on B-cell chronic lymphocytic leukemia (B-CLL) cells. All drugs were able to induce a high percentage of apoptosis on B-CLL cells from all patients studied. However, only AG490 and WHI-P131 were able to strongly suppress the STAT1 activation of B-CLL cells. In conclusion, our data show that JAK kinase inhibitors, such as AG490 and WHI-P131 are able to inhibit the STAT1 pathway on B-CLL cells and are strong inductors of apoptosis on these cells.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Apoptosis / drug effects*
-
Cell Survival / drug effects
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / physiology*
-
Electrophoretic Mobility Shift Assay
-
Female
-
Flow Cytometry
-
Humans
-
Interferon-gamma / pharmacology
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Male
-
Middle Aged
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Quinazolines / pharmacology*
-
STAT1 Transcription Factor
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
-
Time Factors
-
Trans-Activators / antagonists & inhibitors
-
Trans-Activators / physiology*
-
Tumor Cells, Cultured
-
Tyrphostins / pharmacology*
-
Vidarabine / analogs & derivatives*
-
Vidarabine / pharmacology*
Substances
-
DNA-Binding Proteins
-
Quinazolines
-
STAT1 Transcription Factor
-
STAT1 protein, human
-
Trans-Activators
-
Tyrphostins
-
WHI P131
-
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
-
Interferon-gamma
-
Protein-Tyrosine Kinases
-
Vidarabine
-
fludarabine